Ipsen Biopharm Ltd appoints an Early Development Asset Lead to drive integrated strategy across preclinical to first-in-human stages. The role leads the EDT, coordinating clinical, regulatory, CMC, translational, and biomarker activities to ensure rigorous, evidence-based program progression with portfolio alignment.
Strong scientific leadership, external evaluation experience, and a track record in oncology drug development are essential.
#J-18808-Ljbffr
Senior Early Development Asset Lead employer: Ipsen Pharma (SAS)
Ipsen Pharma is an exceptional employer that prioritises employee growth and innovation within a collaborative and inclusive work culture. With a strong commitment to human-centric leadership, employees are empowered to thrive while contributing to meaningful projects that impact patients' lives globally. Located in vibrant hubs like London and Paris, Ipsen offers unique opportunities for professional development and the chance to be at the forefront of transformative biopharmaceutical advancements.
